封面
市场调查报告书
商品编码
1746862

2025-2033年日本生物光子学市场技术、应用及地区报告

Japan Biophotonics Market Report by Technique, Technology, Application, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 118 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年,日本生物光子学市场规模达35.19亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到76.34亿美元,2025-2033年期间的复合年增长率(CAGR)为9%。癌症和神经系统疾病等疾病发病率的上升、对精准诊断工具和标靶治疗的需求日益增长、对精准农业的日益重视、政府倡议和资金支持的不断增加,以及向分散式医疗保健和即时检测的转变,都是推动市场发展的一些因素。

生物光子学是生物学与光子学交叉学科,探索生物组织与光的相互作用。这个新兴研究领域涵盖多种技术,利用光的独特特性在分子和细胞层面研究、诊断和治疗生物组织。它结合各种光学方法,包括萤光成像、拉曼光谱和光学相干断层扫描,以捕捉和分析生物样本的光学特征。此领域已广泛应用于医学诊断、神经科学和环境监测等多个领域。在医学领域,生物光子学在非侵入性影像技术中发挥关键作用,有助于早期疾病检测和指导微创外科手术。此外,它还促进了细胞过程和相互作用的研究,揭示了生物学的基本原理。受成像技术、雷射系统和新型光学探针发展的推动,生物光子学的应用正在迅速扩展。此外,它还为蓬勃发展的诊疗学领域做出了贡献,该领域将诊断和治疗整合为单一方法。随着生物光子学的不断发展,它有望透过提供强大的微观和分子尺度的可视化和操控工具,彻底改变医疗保健和生物学研究,最终增强我们对生命系统的理解,并改善诊断和治疗效果。

日本生物光子学市场趋势:

日本市场主要受其在各行各业的广泛应用和变革潜力所驱动。同时,医疗领域对非侵入性诊断技术日益增长的需求,也显着促进了市场成长。此外,萤光成像和光学相干断层扫描等生物光子学技术使临床医生无需侵入性操作即可在细胞和分子层面上观察组织,从而提高了诊断准确性和早期疾病检测能力。这反过来又对市场产生了正面影响。此外,成像技术的快速发展和先进光学探头的研发也大大促进了市场扩张。雷射系统、侦测器和成像模式的持续创新使检测更加精确和灵敏,使生物光子学成为生物和医学研究中日益不可或缺的工具。此外,慢性病的日益普及和全球人口老化加剧了对先进医疗诊断和治疗的需求。生物光子学在理解疾病的分子基础、促进个人化医疗和指导标靶治疗方面发挥着至关重要的作用,这与精准医疗的大趋势相契合。除了医疗保健领域,生物光子学正在农业和环境监测等其他产业取得重大进展。生物光子学能够对生物材料进行即时、无损分析,可用于食品和农产品的品质控制以及环境污染物监测。生物光子学的协作特性融合了光子学、生物学和医学领域的专业知识,促进了跨学科的研发。这种跨学科方法催生了一个充满活力的创新生态系统,推动了新技术和新应用的诞生。此外,公共和私营部门对研发项目的大力投入正在加速生物光子学的进步。这些投入不仅支持现有技术的改进,也为发现新的应用和开发更具成本效益的解决方案铺平了道路。随着对生物光子学理解的不断深入和新应用的不断涌现,生物光子学市场有望持续成长,为医疗保健、科学研究和各行各业的复杂挑战提供变革性的解决方案。

日本生物光子学市场细分:

技术见解:

  • 表面成像
  • 分子光谱学
  • 显微镜
  • 光疗法
  • 生物感测器
  • 内部影像
  • 透视成像
  • 其他的

技术洞察:

  • 体外
  • 体内

应用程式洞察:

  • 医疗诊断
  • 医学治疗学
  • 材料测试
  • 其他的

竞争格局:

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外,报告还提供了所有主要公司的详细资料。

本报告回答的关键问题:

  • 日本生物光子学市场迄今表现如何?未来几年将如何表现?
  • COVID-19 对日本生物光子学市场有何影响?
  • 日本生物光子学市场依技术分類的分布如何?
  • 日本生物光子学市场依技术分類的分布如何?
  • 日本生物光子学市场根据应用如何划分?
  • 日本生物光子学市场的价值链分为哪些阶段?
  • 日本生物光子学的主要驱动因素和挑战是什么?
  • 日本生物光子学市场的结构是怎么样的?主要参与者是谁?
  • 日本生物光子学市场的竞争程度如何?

本报告回答的关键问题:

  • 日本生物光子学市场迄今表现如何?未来几年将如何表现?
  • COVID-19 对日本生物光子学市场有何影响?
  • 日本生物光子学市场依技术分類的分布如何?
  • 日本生物光子学市场依技术分類的分布如何?
  • 日本生物光子学市场根据应用如何划分?
  • 日本生物光子学市场的价值链分为哪些阶段?
  • 日本生物光子学的主要驱动因素和挑战是什么?
  • 日本生物光子学市场的结构是怎么样的?主要参与者是谁?
  • 日本生物光子学市场的竞争程度如何?

目录

第一章:前言

第二章:范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章:执行摘要

第四章:日本生物光子学市场 - 简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章:日本生物光子学市场格局

  • 历史与当前市场趋势(2019-2024)
  • 市场预测(2025-2033)

第六章:日本生物光子学市场-细分:依技术

  • 表面成像
    • 概述
  • 分子光谱学
    • 概述
  • 显微镜
    • 概述
  • 光疗法
    • 概述
  • 生物感测器
    • 概述
  • 内部影像
    • 概述
  • 透视成像
    • 概述
  • 其他的

第七章:日本生物光子学市场-细分:依技术

  • 体外
    • 概述
  • 体内
    • 概述

第 8 章:日本生物光子学市场 - 细分:按应用

  • 医疗诊断
    • 概述
  • 医学治疗学
    • 概述
  • 材料测试
    • 概述
  • 其他的

第九章:日本生物光子学市场-竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第十章:关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章:日本生物光子学市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 12 章:附录

简介目录
Product Code: SR112025A18963

Japan biophotonics market size reached USD 3,519 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7,634 Million by 2033, exhibiting a growth rate (CAGR) of 9% during 2025-2033. The increasing incidence of diseases such as cancer and neurological disorders, the rising need for precise diagnostic tools and targeted therapies, the growing emphasis on precision farming, the escalating government initiatives and funding support, and the shift towards decentralized healthcare and point-of-care testing are some of the factors propelling the market.

Biophotonics, an interdisciplinary field at the intersection of biology and photonics, explores the interaction between biological tissues and light. This emerging area of study encompasses a diverse range of technologies and techniques that leverage the unique properties of light to investigate, diagnose, and treat biological tissues at the molecular and cellular levels. It incorporates various optical methods, including fluorescence imaging, Raman spectroscopy, and optical coherence tomography, to capture and analyze the optical signatures of biological samples. The field has found application in diverse areas, such as medical diagnostics, neuroscience, and environmental monitoring. In medical contexts, biophotonics plays a pivotal role in non-invasive imaging techniques, enabling early disease detection and guiding minimally invasive surgical procedures. Additionally, it facilitates the study of cellular processes and interactions, shedding light on fundamental aspects of biology. The utilization of biophotonics is expanding rapidly, driven by advancements in imaging technologies, laser systems, and the development of novel optical probes. Furthermore, it contributes to the burgeoning field of theranostics, where diagnostics and therapy are integrated into a single approach. As biophotonics continues to evolve, it promises to revolutionize healthcare and biological research by providing powerful tools for visualization and manipulation at the microscopic and molecular scales, ultimately enhancing our understanding of living systems and improving diagnostic and therapeutic outcomes.

Japan Biophotonics Market Trends:

The market in Japan is majorly driven by the versatile applications and transformative potential across various industries. In line with this, the escalating demand for non-invasive diagnostic techniques in the medical field is significantly contributing to the market growth. Furthermore, biophotonics technologies, such as fluorescence imaging and optical coherence tomography, allow clinicians to visualize tissues at the cellular and molecular levels without requiring invasive procedures, enhancing diagnostic accuracy and early disease detection. This, in turn, is positively influencing the market. Besides, the rapid advancements in imaging technologies and the development of sophisticated optical probes contribute substantially to market expansion. Continuous innovations in laser systems, detectors, and imaging modalities enable more precise and sensitive detection, making biophotonics an increasingly indispensable tool in biological and medical research. Moreover, the growing prevalence of chronic diseases and the aging global population fuel the demand for advanced medical diagnostics and treatments. Biophotonics plays a crucial role in understanding the molecular basis of diseases, facilitating personalized medicine, and guiding targeted therapies, aligning with the broader trend of precision healthcare. In addition to healthcare, biophotonics is making significant inroads into other industries, such as agriculture and environmental monitoring. The ability of biophotonics to provide real-time, non-destructive analysis of biological materials has applications in quality control for food and agricultural products, as well as in monitoring environmental pollutants. The collaborative nature of biophotonics, bringing together expertise from photonics, biology, and medicine, fosters interdisciplinary research and development. This interdisciplinary approach fosters a dynamic ecosystem of innovation, driving the creation of new technologies and applications. Additionally, the heavy investments in research and development initiatives, both from the public and private sectors, are accelerating the pace of advancements in biophotonics. These investments not only support the refinement of existing technologies but also pave the way for the discovery of novel applications and the development of more cost-effective solutions. As the understanding of biophotonics continues to deepen and new applications emerge, the market is poised for sustained growth, offering transformative solutions that address complex challenges in healthcare, research, and various industries.

Japan Biophotonics Market Segmentation:

Technique Insights:

  • Surface Imaging
  • Molecular Spectroscopy
  • Microscopy
  • Light Therapy
  • Biosensors
  • Inside Imaging
  • See-through Imaging
  • Others

Technology Insights:

  • In-Vitro
  • In-Vivo

Application Insights:

  • Medical Diagnostics
  • Medical Therapeutics
  • Material Testing
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan biophotonics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan biophotonics market?
  • What is the breakup of the Japan biophotonics market on the basis of technique?
  • What is the breakup of the Japan biophotonics market on the basis of technology?
  • What is the breakup of the Japan biophotonics market on the basis of application?
  • What are the various stages in the value chain of the Japan biophotonics market?
  • What are the key driving factors and challenges in the Japan biophotonics?
  • What is the structure of the Japan biophotonics market and who are the key players?
  • What is the degree of competition in the Japan biophotonics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biophotonics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Biophotonics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Biophotonics Market - Breakup by Technique

  • 6.1 Surface Imaging
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Molecular Spectroscopy
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Microscopy
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Light Therapy
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Biosensors
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)
  • 6.6 Inside Imaging
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2019-2024)
    • 6.6.3 Market Forecast (2025-2033)
  • 6.7 See-through Imaging
    • 6.7.1 Overview
    • 6.7.2 Historical and Current Market Trends (2019-2024)
    • 6.7.3 Market Forecast (2025-2033)
  • 6.8 Others
    • 6.8.1 Historical and Current Market Trends (2019-2024)
    • 6.8.2 Market Forecast (2025-2033)

7 Japan Biophotonics Market - Breakup by Technology

  • 7.1 In-Vitro
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 In-Vivo
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan Biophotonics Market - Breakup by Application

  • 8.1 Medical Diagnostics
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Medical Therapeutics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Material Testing
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Others
    • 8.4.1 Historical and Current Market Trends (2019-2024)
    • 8.4.2 Market Forecast (2025-2033)

9 Japan Biophotonics Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Biophotonics Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix